D-0007-2015 Class II Terminated
FDA drug recall D-0007-2015 was initiated by Zydus Pharmaceuticals USA Inc on Aug 5, 2014 and is designated Class II. Reason for recall: Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance. The recall status is terminated (terminated Sep 22, 2017). Affected quantity: 5400 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2014
- Initiation Date
- Aug 5, 2014
- Termination Date
- Sep 22, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5400 bottles
Product description
ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01
Reason for recall
Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.
Distribution pattern
Nationwide
Code information
MP2292 Exp. 01/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0007-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026